Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Alpine Associates Trims Stake in Ocata Therapeutics, Inc. (OCAT)

We are seeing a deluge of 13G filing activity at the moment given the quarterly filing deadline for end-of-year reporting is upon us. One of the more up-to-date filings is this one submitted to the SEC by Robert Emil Zoellner‘s Alpine Associates. This filing details the investor’s latest position in Ocata Therapeutics Inc. (NASDAQ:OCAT), including the amount of shares owned at 2.09 million and the total voting power held by the investor (you can see these figures in the table below). As you can see below, Alpine Associates’ ownership has now dipped below 5% of Ocata Therapeutics’ common stock, which prompted the updated filing. The current position represents a decrease of about 320,000 shares from the position that Alpine Associates held in the stock at the end of 2015.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
A 2,092,204 2,092,204 2,092,204 4.95%
Robert Emil Zoellner
Robert Emil Zoellner
Alpine Associates

Page 1 of 1 SEC Filing

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
—————-

SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*

—————-

Ocata Therapeutics, Inc.
————————————————————————–
(Name of Issuer)

Common Stock, $0.001 par value per share
————————————————————————–
(Title of Class of Securities)

67457L100
————————————————————————–
(CUSIP Number)

February 3, 2016
————————————————————————–
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:

[X] Rule 13d-1(b)

[ ] Rule 13d-1(c)

[ ] Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be
deemed to be “filed” for the purpose of Section 18 of the Securities and
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that
section of that Act but shall be subject to all other provisions of the Act
(however, see the Notes).

Page 1 of 4
—————————————————————————-

====================
CUSIP No. 543524300 13G
====================

—————————————————————————-
1 NAMES OF REPORTING PERSONS Alpine Associates Management Inc.
—————————————————————————-
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A) [ ]
(B) [X]
—————————————————————————-
3 SEC USE ONLY
—————————————————————————-
4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
—————————————————————————-
5 SOLE VOTING POWER 2,092,204
NUMBER OF SHARES ———————————————————-
BENEFICIALLY 6 SHARED VOTING POWER None
OWNED BY ———————————————————-
EACH REPORTING 7 SOLE DISPOSITIVE POWER 2,092,204
PERSON WITH: ———————————————————-
8 SHARED DISPOSITIVE POWER None
—————————————————————————-
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY
EACH REPORTING PERSON 2,092,204 (See Note 1 to Item 4 below)
—————————————————————————-
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) [ ]
EXCLUDES CERTAIN SHARES (See Instructions)
—————————————————————————-
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.95%
—————————————————————————-
12 TYPE OF REPORTING PERSON IA
—————————————————————————-

Page 2 of 4
—————————————————————————-

Item 1(a) Name of Issuer:

Ocata Therapeutics, Inc.

Item 1(b) Address of Issuer’s Principal Executive Offices:

33 Locke Drive
Marlborough, MA 01752

Item 2(a) Name of Person Filing:

Alpine Associates Management Inc.

Item 2(b) Address of Principal Business Office:

574 Sylvan Avenue, Suite 100
Englewood Cliffs, NJ 07632

Item 2(c) Citizenship:

Delaware

Item 2(d) Title of Class of Securities:

Common Stock, $0.001 par value per share

Item 2(e) CUSIP Number:

67457L100

Item 3

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c),
check whether the person filing is a:

(a) [ ] Broker or dealer registered under Section 15 of the Act;

(b) [ ] Bank as defined in Section 3(a)(6) of the Act;

(c) [ ] Insurance company as defined in Section 3(a)(19) of the Act;

(d) [ ] Investment company registered under Section 8 of the Investment
Company Act of 1940

(e) [X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)ii)(F);

(g) [ ] A parent holding company or control person in accordance with
Rule 13d-1(b)(1(ii)(G);

(h) [ ] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment Company
Act of 1940;

(j) [ ] A non-U.S. institution in accordance with Rule 240.13d-
1(b)(1)(ii)(J);

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If
filing as a non-U.S. institution in accordance with Rule 240.13d-
1(b)(1)(ii)(J), please specify the type of institution: __________

Page 3 of 4
—————————————————————————-

Item 4 Ownership

(a) Amount beneficially owned: 2,092,204 (see Note 1)

(b) Percent of class: 4.95%

(c) Number of shares to which such person has:

(i) Sole power to vote or direct the vote: 2,092,204 (see Note 1)

(ii) Shared power to vote or direct the vote: None

(iii) Sole power to dispose or direct disposition of:
2,092,204 (see Note 1)

(iv) Shared power to dispose or direct disposition of: None

Note 1: Alpine Associates Management Inc. (“Alpine”), an investment advisor
that is registered under the Investment Advisors Act of 1940, furnishes
investment advice to and manages onshore and offshore investment funds and
separate managed accounts (such investment funds and accounts, the “Funds”).
In its role as investment advisor and manager Alpine possesses voting and/or
investment power over the securities of the Issuer described in this schedule
that are owned by the Funds. All securities reported in this schedule are
owned by the Funds. Alpine disclaims beneficial ownership of such
securities.

Item 5 Ownership of 5% or Less of a Class

If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more
than 5 percent of the class of securities, check the following [X].

Item 6 Ownership of More than 5% on Behalf of Another Person

Not applicable

Item 7 Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company or
Control Person

Not applicable

Item 8 Identification and Classification of Members of the Group

Not applicable

Item 9 Notice of Dissolution of Group

Not applicable

Item 10 Certification

By signing the below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired and are held in the ordinary
course of business and were not acquired and are not held for the purpose of
or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or
as a participant in any transaction having that purpose or effect.

Page 4 of 4
—————————————————————————-

Signature

After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.

Date: February 16, 2016

/s/ Todd Mason
—————————-
Todd Mason
Chief Operating Officer, Alpine Associates Management Inc.

Follow Ocata Therapeutics Inc. (NASDAQ:OCAT)
Trade (NASDAQ:OCAT) Now!
Loading...